Young blood for old hands? A recent anti-ageing trial prompts ethical questions

Nikola Biller-Andorno

doi:10.4414/smw.2016.14359

Viewpoint

Vol. 146 No. 3940 (2016)

Young blood for old hands? A recent anti-ageing trial prompts ethical questions

Nikola Biller-Andorno

DOI: https://doi.org/10.4414/smw.2016.14359
Cite this as:: Swiss Med Wkly. 2016;146:w14359
Published: 29.09.2016

References

Werner M. Bis bald (See you soon). Frankfurt a.M.: Fischer, 2011.
Federal Office of Public Health (FOPH): Confederation and cantons take action against providers of illegal fresh cell therapy. Media release, March 26, 2015. https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-56686.html
Eggel A, Wyss-Coray T. A revival of parabiosis in biomedical research. Swiss Med Wkly. 2014;144:w13914. http://www.smw.ch/content/smw-2014-13914/
Villeda SA, Plambeck EK, Middeldorp J, Castellano JM, Moshere KI, LuoJ, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nature. 2014;477:90–4.
Shytikov D, Balva O, Debonneuil E, Glukhovskiv P, Pishel I. Aged mice repeatedly injected with plasma from young mice: a survival study. Biores Open Access. 2014;3(5):226–32. doi: 10.1089/biores.2014.0043.
Kaiser J. Antiaging trial using young blood stirs concerns. Science. 2016;353:527–8.
Scudellari M. Ageing research: Blood to blood. Nature 2015;517:426–9, doi:10.1038/517426a.
Schulz-Baldes A, Biller-Andorno N, Capron A. International perspectives on the ethics and regulation of human cell and tissue transplantation. World Health Bulletin. 2007;85(12):941–8.
Thompson JJ. A defense of abortion. Philosophy & Public Affairs. 1971;1(1):47–66.

How to Cite

1.

Biller-Andorno N. Young blood for old hands? A recent anti-ageing trial prompts ethical questions. Swiss Med Wkly [Internet]. 2016 Sep. 29 [cited 2024 Dec. 12];146(3940):w14359. Available from: https://smw.ch/index.php/smw/article/view/2227

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Giovanni Spitale, Andrea Glässel, Mirriam Tyebally-Fang, Corine Mouton Dorey, Nikola Biller-Andorno, Patient narratives – a still undervalued resource for healthcare improvement , Swiss Medical Weekly: Vol. 153 No. 1 (2023)
Margrit Fässler, Verina Wild, Caroline Clarinval, Alois Tschopp, Jana Alexandra Faehnrich, Nikola Biller-Andorno, Impact of the DRG-based reimbursement system on patient care and professional practise: perspectives of Swiss hospital physicians , Swiss Medical Weekly: Vol. 145 No. 0708 (2015)
Sophie Gloeckler, Nikola Biller-Andorno, Mental health services in the metaverse: potential and concerns , Swiss Medical Weekly: Vol. 153 No. 4 (2023)
Verina Wild, Fourie Carina, Regula Frouzakis, Caroline Clarinval, Margrit Fässler, Bernice Elger, Thomas Gächter, Agnes Leu, Rebecca Spirig, Michael Kleinknecht, Dragana Radovanovic, Corine Mouton Dorey, Bernard Burnand, John-Paul Vader, Jean-Marie Januel, Nikola Biller-Andorno, The IDoC group, Assessing the impact of DRGs on patient care and professional practice in Switzerland (IDoC) – a potential model for monitoring and evaluating healthcare reform , Swiss Medical Weekly: Vol. 145 No. 0708 (2015)
Tania Manríquez Roa, Nikola Biller-Andorno, Financial incentives for participants in health research: when are they ethical? , Swiss Medical Weekly: Vol. 152 No. 1112 (2022)
Tania Manríquez Roa, Markus Christen, Andreas Reis, Nikola Biller-Andorno, The pursuit of health equity in the era of artificial intelligence , Swiss Medical Weekly: Vol. 153 No. 1 (2023)
Julian W. März, Tania Manríquez Roa, Bettina Schwind, Nikola Biller-Andorno, Monkeypox, bioethics and the LGBTQI+ community , Swiss Medical Weekly: Vol. 152 No. 4344 (2022)
Helena Hermann, Manuel Trachsel, Christine Mitchell, Nikola Biller-Andorno, Medical decision-making capacity: knowledge, attitudes, and assessment practices of physicians in Switzerland , Swiss Medical Weekly: Vol. 144 No. 4142 (2014)
Matthew J. Kerry, Thomas Volken, Nikola Biller-Andorno, Andrea Glässel, Markus Melloh, A Swiss digital Delphi study on patient-reported outcomes , Swiss Medical Weekly: Vol. 153 No. 11 (2023)
Ana Rosca, Tanja Krones, Nikola Biller-Andorno, Shared decision making: patients have a right to be informed about possible treatment options and their risks and benefits , Swiss Medical Weekly: Vol. 150 No. 2728 (2020)

1 2 > >>

[1] Werner M. Bis bald (See you soon). Frankfurt a.M.: Fischer, 2011.

[2] Federal Office of Public Health (FOPH): Confederation and cantons take action against providers of illegal fresh cell therapy. Media release, March 26, 2015. https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-56686.html

[3] Eggel A, Wyss-Coray T. A revival of parabiosis in biomedical research. Swiss Med Wkly. 2014;144:w13914. http://www.smw.ch/content/smw-2014-13914/

[4] Villeda SA, Plambeck EK, Middeldorp J, Castellano JM, Moshere KI, LuoJ, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nature. 2014;477:90–4.

[5] Shytikov D, Balva O, Debonneuil E, Glukhovskiv P, Pishel I. Aged mice repeatedly injected with plasma from young mice: a survival study. Biores Open Access. 2014;3(5):226–32. doi: 10.1089/biores.2014.0043.

[6] Kaiser J. Antiaging trial using young blood stirs concerns. Science. 2016;353:527–8.

[7] Scudellari M. Ageing research: Blood to blood. Nature 2015;517:426–9, doi:10.1038/517426a.

[8] Schulz-Baldes A, Biller-Andorno N, Capron A. International perspectives on the ethics and regulation of human cell and tissue transplantation. World Health Bulletin. 2007;85(12):941–8.

[9] Thompson JJ. A defense of abortion. Philosophy & Public Affairs. 1971;1(1):47–66.